Measuring inconsistency in meta-analyses
Reads0
Chats0
TLDR
A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.Abstract:
Cochrane Reviews have recently started including the quantity I 2 to help readers assess the consistency of the results of studies in meta-analyses. What does this new quantity mean, and why is assessment of heterogeneity so important to clinical practice?
Systematic reviews and meta-analyses can provide convincing and reliable evidence relevant to many aspects of medicine and health care.1 Their value is especially clear when the results of the studies they include show clinically important effects of similar magnitude. However, the conclusions are less clear when the included studies have differing results. In an attempt to establish whether studies are consistent, reports of meta-analyses commonly present a statistical test of heterogeneity. The test seeks to determine whether there are genuine differences underlying the results of the studies (heterogeneity), or whether the variation in findings is compatible with chance alone (homogeneity). However, the test is susceptible to the number of trials included in the meta-analysis. We have developed a new quantity, I 2, which we believe gives a better measure of the consistency between trials in a meta-analysis.
Assessment of the consistency of effects across studies is an essential part of meta-analysis. Unless we know how consistent the results of studies are, we cannot determine the generalisability of the findings of the meta-analysis. Indeed, several hierarchical systems for grading evidence state that the results of studies must be consistent or homogeneous to obtain the highest grading.2–4
Tests for heterogeneity are commonly used to decide on methods for combining studies and for concluding consistency or inconsistency of findings.5 6 But what does the test achieve in practice, and how should the resulting P values be interpreted?
A test for heterogeneity examines the null hypothesis that all studies are evaluating the same effect. The usual test statistic …read more
Citations
More filters
Journal ArticleDOI
Exercise for type 2 diabetes mellitus
TL;DR: The meta-analysis shows that exercise significantly improves glycaemic control and reduces visceral adipose tissue and plasma triglycerides, but not plasma cholesterol, in people with type 2 diabetes, even without weight loss.
Journal ArticleDOI
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
Jasper J. Brugts,Tuncay Yetgin,Sanne E. Hoeks,Antonio M. Gotto,J. Shepherd,Rudi G. J. Westendorp,A.J.M. de Craen,R. H. Knopp,Haruo Nakamura,Paul M. Ridker,R. Van Domburg,Jaap W. Deckers +11 more
TL;DR: In patients without established cardiovascular disease but with cardiovascular risk factors, statin use was associated with significantly improved survival and large reductions in the risk of major cardiovascular events.
Journal ArticleDOI
Physical Activity and Incident Depression: A Meta-Analysis of Prospective Cohort Studies
Felipe Barreto Schuch,Davy Vancampfort,Joseph Firth,Simon Rosenbaum,Phillip B. Ward,Edson Soares da Silva,Mats Hallgren,Antonio Ponce de Leon,Andrea L. Dunn,Andrea Camaz Deslandes,Marcelo Pio de Almeida Fleck,André F. Carvalho,Brendon Stubbs +12 more
TL;DR: In this paper, the prospective relationship between physical activity and incident depression was examined and potential moderators explored, and a prospective cohort study evaluating incident depression and physical activity was conducted. But the results were limited.
Journal ArticleDOI
Comprehensive geriatric assessment for older adults admitted to hospital
Graham Ellis,Michael P. Gardner,Apostolos Tsiachristas,Peter Langhorne,Orlaith Burke,Rowan H. Harwood,Simon Conroy,Tilo Kircher,Dominique Somme,Ingvild Saltvedt,Heidi L. Wald,Desmond O'Neill,David Robinson,Sasha Shepperd +13 more
TL;DR: This update of a previously published Cochrane review sought to critically appraise and summarise current evidence on the effectiveness and resource use of CGA for older adults admitted to hospital, and to estimate its cost-effectiveness.
Journal ArticleDOI
Association between smoking and risk of bladder cancer among men and women
Neal D. Freedman,Debra T. Silverman,Albert R. Hollenbeck,Arthur Schatzkin,Christian C. Abnet +4 more
TL;DR: Compared with a pooled estimate of US data from cohorts initiated between 1963 and 1987, relative risks for smoking in the more recent NIH-AARP Diet and Health Study cohort were higher, with PARs for women comparable with those for men.
References
More filters
Journal ArticleDOI
Quantifying heterogeneity in a meta‐analysis
TL;DR: It is concluded that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity, and one or both should be presented in publishedMeta-an analyses in preference to the test for heterogeneity.
Journal ArticleDOI
The combination of estimates from different experiments.
TL;DR: The problem of making a combined estimate has been discussed previously by Cochran and Yates and Cochran (1937) for agricultural experiments, and by Bliss (1952) for bioassays in different laboratories as discussed by the authors.
Journal ArticleDOI
Tamoxifen for early breast cancer: An overview of the randomised trials
TL;DR: The absolute improvement in recurrence was greater during the first 5 years, whereas the improvement in survival grew steadily larger throughout the first 10 years, and these benefits appeared to be largely irrespective of age, menopausal status, daily tamoxifen dose, and of whether chemotherapy had been given to both groups.
Journal Article
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group
TL;DR: There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated overview of their results is presented in this paper, which approximately doubles the amount of evidence from trials of about 5 years of tamoxifier and, taking all trials together, on events occurring more than 5 years after randomisation.
Journal ArticleDOI
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.
TL;DR: In this paper, the authors evaluated standard error, precision (inverse of standard error), variance, inverse of variance, sample size and log sample size (vertical axis) and log odds ratio, log risk ratio and risk difference (horizontal axis).